Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kobotide injection for herpes zoster pain relief and prevention of postherpetic neuralgia
ChiCTR2300072115Phase 4Recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Jun 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of kobotide in herpes zoster (HZ) (2 arms), sponsored by First Hospital of China Medical University. Primary endpoint: Pain relief. Started Jun 2023; status: recruiting.
02
Drugs
kobotide
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR2300072115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072115.